Top Supermarket Companies To Watch For 2014

It might not be obvious to the casual observer, but right now, today, Kroger (NYSE: KR  ) stock offers one of the best values available in the supermarket industry. Why?

Three reasons.

Kroger is cheap
When you stack up Kroger stock against a couple of its smaller, faster-growing rivals -- Harris Teeter (NYSE: HTSI  ) and The Fresh Market (NASDAQ: TFM  ) , it's clear that Kroger is the cheapest of the three. Its 12.0 price-to-earnings ratio is barely half the price Harris Teeter stock-shoppers pay, and less than a third of the price of a share of Fresh Market.

Now as I just mentioned, both Harris Teeter and Fresh Market are growing faster than Kroger. Analysts have Kroger pegged for a bit more than 7% annual earnings growth over the next five years, while Harris is expected to grow a bit less than twice as fast, and Fresh Market a bit less than three times as fast. Emphasis on "a bit less" -- as in, the disparities in growth rates aren't big enough to justify the discounts on Kroger stock: about two times versus Harris, and more than three times versus Fresh Market.

Top Penny Companies To Watch For 2015: RWE AG (RWE)

RWE AG is a Germany-based electricity and gas company. It diversifies its activities into seven divisions: Germany, which consists of the Power Generation and Sales and Distribution Networks business area; Netherlands/Belgium; Great Britain; The Central Eastern and South Eastern Europe; Renewables; Upstream Gas and Oil, and Trading/Gas Midstream. Under the Netherlands/Belgium division it reports on wholly owned Essent, which provides gas, electricity, heat and energy services. The United Kingdom division represents RWE npower; The Central Eastern and South Eastern Europe division covers its subsidiaries in Poland, Hungary, the Czech Republic, Turkey and Slovakia. The Renewables division comprises all of the activities of RWE Innogy, which specializes in electricity and heat generation from renewables. The Upstream Gas & Oil division produces gas and oil through RWE Dea. The Trading/Gas Midstream division encompasses energy trading, gas midstream activities, and sales to German clients. Advisors' Opinion:

• [By Jonathan Morgan]

  RWE AG (RWE) jumped 6.4 percent, leading a gauge of utilities higher. Deutz AG (DEZ) plunged the most in more than two years after an investor sold a 8.4 percent stake in the manufacturer of diesel engines. ProSiebenSat.1 Media AG (PSM) dropped 1.1 percent after Telegraaf Media Groep NV sold its stake in the company.

• [By Jonathan Morgan]

  RWE AG (RWE), Germany�� second-largest utility, slipped 2.4 percent after RBC Capital Markets cut its recommendation on the stock. Lufthansa followed its European peers higher, recovering some of its Aug. 2 selloff. Xing AG (O1BC), the business social network, jumped the most since October as Deutsche Bank AG (DBK) upgraded its rating on the shares.

Top Supermarket Companies To Watch For 2014: Home Federal Bancorp Inc. of Louisiana(HFBL)

Home Federal Bancorp, Inc. of Louisiana operates as the holding company for Home Federal Bank, which provides financial services to individuals, corporate entities, and other organizations in northwest Louisiana. The company?s deposit products include savings accounts, NOW accounts, money market accounts, and certificate accounts, as well as passbook savings, certificates of deposit, and demand deposit accounts. Its loan portfolio comprises real estate loans, such as one to four family residential loans; commercial-real estate loans; multi-family residential loans; commercial business loans; land loans; construction loans; home equity and second mortgage loans; equity lines of credit; and consumer loans, including loans secured by deposit accounts, automobile loans, and other unsecured loans. The company also offers wealth management services. As of December 7, 2010, it operated through its main office, two branch offices, and one agency office in Shreveport, Louisiana. T he company is based in Shreveport, Louisiana.

Advisors' Opinion:

• [By Lauren Pollock]

  Bank-holding company Banner Corp.(BANR) on Tuesday said it had agreed to buy Home Federal Bancorp Inc.(HFBL) (HOME) for $197 million in cash and stock. The deal, expected to close in the first quarter of 2014, will result in a combined company with about $5.2 billion in assets, making it the fourth-largest bank in the Pacific Northwest by assets, the companies said.

Top Supermarket Companies To Watch For 2014: Ryland Group Inc (RYL)

The Ryland Group, Inc., incorporated on March 28, 1967, is a homebuilders and a mortgage-finance company. In addition, Ryland Mortgage Company and its subsidiaries, and RMC Mortgage Corporation (collectively referred to as RMC) provide mortgage financing and related services. All of the Company's business is conducted and located in the United States. The Company's operations span aspects of the home buying process from design, construction and sale to mortgage origination, title insurance, escrow and insurance services. During the year ended December 31, 2012, the homebuilding operations were consisted of approximately 97% of consolidated revenues. The homebuilding segments generate their revenues from sales of completed homes, with sales of land and lots. The Company builds homes for entry-level buyers, as well as for first- and second-time move-up buyers. In July 2012, the Company acquired Charlotte and Raleigh operations and assets of Timberstone Homes. In December 2012, the Company acquired Phoenix operations and assets of Trend Homes. In June 2013, Ryland Group Inc acquired LionsGate Homes Corp. Effective July 19, 2013, Ryland Group Inc acquired Cornell Homes, a media-based construction company.

Homebuilding

The Company's homes are built on-site and marketed in four geographic regions or segments: North, Southeast, Texas and West. Its North segment includes Baltimore, Chicago, Indianapolis, Minneapolis, Northern Virginia and Washington, D.C. Its Southeast include Atlanta, Charleston, Charlotte, Orlando and Tampa. Texas includes Austin, Houston and San Antonio. West includes Denver, Las Vegas and Southern California. During 2012, within each of those segments, the Company operated in the metropolitan areas of North, Southeast, Texas and West. Each of its homebuilding divisions across the country consists of a division president; a controller; management personnel focused on land entitlement, acquisition and development, sales, construction, customer service and purchasin! g, and accounting and administrative personnel. The Company markets attached and detached single-family homes. In the Company's single-family detached home communities, it offers at least four different floor plans. The Company's attached home communities offer different floor plans with two, three or four bedrooms. The Company relies on its own architectural staff and also engages unaffiliated architectural firms to develop new designs. Homebuyers are able to customize certain features of their homes by selecting from options and upgrades displayed in the Company's model homes and design centers. In all of the Company's communities, a range of options is available to homebuyers for additional charges. The number and complexity of options increase with the size and base selling price of the home. During 2012, custom options contributed 16.9% of homebuilding revenues.

The Company's financial services segment provides mortgage-related products and services, as well as title, escrow and insurance services, to its homebuyers. The Company's financial services segment includes RMC, RH Insurance Company, Inc. (RHIC), LPS Holdings Corporation and its subsidiaries (LPS), and Columbia National Risk Retention Group, Inc. (CNRRG). By aligning its operations with the Company's homebuilding segments, the financial services segment leverages this relationship to offer its lending services to homebuyers.

During 2012, RMC's mortgage origination operations consisted of the Company's homebuilder loans, which were originated in connection with sales of the Company's homes. During 2012, mortgage operations originated 3,039 loans, which used for purchasing homes built by the Company and for purchasing homes built by others, purchasing existing homes or refinancing existing mortgage loans. RMC arranges various types of mortgage financing, including conventional, Federal Housing Administration (FHA) and Veterans Administration (VA) mortgages, with various fixed- and adjustable-rate features. The Compa! ny sells ! the loans it originates, along with the related servicing rights, to others. Cornerstone Title Company, doing business as Ryland Title Company, is a 100 % subsidiary of RMC, provides escrow and title services and acts as a title insurance agent primarily for the Company's homebuyers. As of December 31, 2012, it provided title services in Arizona, Colorado, Florida, Illinois, Indiana, Maryland, Minnesota, Nevada, Texas and Virginia. Ryland Insurance Services (RIS), a 100 % owned subsidiary of RMC, provides insurance services to the Company's homebuyers. As of December 31, 2012, RIS was licensed to operate in all of the states in which the Company's homebuilding segments operate. During 2012, it provided insurance services to 41.5 % of the Company's homebuyers. CNRRG, a 100 %-owned subsidiary of the Company and some of its affiliates, offer insurance, specifically structural warranty coverage, to protect homeowners against liability risks arising in connection with the homebuilding business of the Company and its affiliates.

Advisors' Opinion:

• [By Rick Aristotle Munarriz]

  Alamy You can never know in advance all the news that will move the market in a given week, but some things you can see coming. From the world's largest consumer tech company posting its iEarnings to a pivotal end to the trading month, here are some of the things that will help shape the week that lies ahead on Wall Street. Monday -- Growing Apples: Lately, Apple (AAPL) hasn't been the growth stock darling that it was through most of the past decade, but it seems to be turning the corner. Apple is expected to post growth in revenue and earnings when it reports fiscal first quarter results on Monday afternoon. It's not likely to be much. Analysts see revenue and earnings per share climbing by no more than 5 percent over last year's holiday quarter. That may seem low given the success of the iPhone 5S and iPad Air that hit the market late last year. However, it's been hard to overcome the slide in Mac and iPod sales. Tuesday -- Comcast Stems the Bleeding: Another company showing renewed signs of life is Comcast (CMCSK). The country's largest cable provider hasn't had a problem growing its Internet and broadband phone services, but it's been struggling since 2007 to keep its pay TV customers around. Comcast finally surprised investors earlier this month by announcing that it closed out the fourth quarter with more subscribers than it had three months earlier. This is the first time that Comcast has posted a sequential increase in video customers after 26 quarters of declines. Comcast reports on Tuesday. Hopefully it will shed some light on this welcome development, letting us know if the cord cutter fears are in the past. Wednesday -- Are We Friends Again: It will be Facebook (FB) hoping that the market clicks "Like" on the leading social networking website's quarterly financials on Wednesday. Facebook had a rocky start as a public company two years ago, going public at $38 and falling into the teens several months later. However, explosive top- and bottom-l

• [By Dan Caplinger]

  Limited tax savings for itemized deductions and municipal-bond interest
  The biggest revenue-raising part of the Obama budget would limit the value of itemized deductions, including the mortgage interest deduction, to 28%. That would impact only high-income taxpayers above the $200,000 and $250,000 income thresholds for single and joint filers, respectively, costing them as much as 11.6 percentage points in tax savings. Because of the high-end focus, the impact on industries like the homebuilding sector that benefit from customers taking advantage of those deductions would be limited, with luxury-oriented companies Toll Brothers (NYSE: TOL  ) and Ryland (NYSE: RYL  ) more at risk than homebuilders aimed at lower price points.

• [By Jeremy Bowman]

  What: Homebuilder shares tanked today as companies including Pulte Group (NYSE: PHM  ) , DR Horton (NYSE: DHI  ) , and Ryland Group (NYSE: RYL  ) were all down by more than 10% at one point as investors bet that the change in Fed policy could kill the housing rally.

Top Supermarket Companies To Watch For 2014: Lee Enterprises Incorporated (LEE)

Lee Enterprises, Incorporated provides local news, information, and advertising services primarily in midsize or small markets in the United States. The company publishes 50 daily and 39 Sunday newspapers, 300 weekly newspapers and classified, and niche publications in 22 states; and provides retail, classified, digital, and national advertising services. It also provides digital infrastructure and digital publishing services for approximately 1,500 daily and weekly newspapers and shoppers. The company was founded in 1890 and is based in Davenport, Iowa.

Advisors' Opinion:

• [By Roberto Pedone]

  Another newspaper publishing player that looks ready to trigger a major breakout trade is Lee Enterprises (LEE), which is a provider of local news and information and a platform for advertising, in primarily midsize markets. This stock has been on fire so far in 2013, with shares up big by 154%.

  >>Hack Earnings Season With These Serial Surprisers

  If you take a look at the chart for Lee Enterprises, you'll notice that this stock is just starting to spike higher back above its 50-day moving average of $2.89 a share with strong upside volume. Volume already today has registered over 360,000 shares, which is quickly approaching its three-month average action of 399,735 shares. This move is quickly pushing shares of LEE within range of triggering a major breakout trade.

  Traders should now look for long-biased trades in LEE if it manages to break out above some near-term overhead resistance levels at $3.14 a share to its 52-week high at $3.20 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 399,735 shares. If that breakout hits soon, then LEE will set up to enter new 52-week-high territory, which is bullish technical price action. Some possible upside targets off that breakout are $4 to $5 a share.

  Traders can look to buy LEE off any weakness to anticipate that breakout and simply use a stop that sits right below some key near-term support levels at $2.71 or at $2.60 a share. One could also buy LEE off strength once it takes out those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.

• [By Jeff Reeves]

  Newspapers are hardly a growth industry, but after such a horrible fall from grace, publisher Lee Enterprises (LEE) may be a decent investment once more.

Top Supermarket Companies To Watch For 2014: Catamaran Corp (CTRX)

Catamaran Corporation (Catamaran), formerly SXC Health Solutions Corp., incorporated on June 27, 2007, is a provider of pharmacy benefit management (PBM) services and healthcare information technology (HCIT) solutions to the healthcare benefit management industry. The Company�� product offerings and solutions combine a range of applications and PBM services designed to assist its customers in reducing the cost and managing the complexity of their prescription drug programs. The Company�� customers include organizations in the pharmaceutical supply chain, such as pharmacy benefit managers, managed care organizations, self-insured employer groups, unions, third party health care plan administrators, and state and federal government entities. In January 2012, the Company completed its acquisition of HealthTran LLC (HealthTran). On July 2, 2012, the Company acquired Catalyst Health Solutions, Inc. On October 1, 2013, the Company acquired RESTAT, LLC.

The Company�� PBM services, which are marketed under the Catamaran PBM brand, include electronic point-of-sale pharmacy claims management, retail pharmacy network management, mail pharmacy claims management, specialty pharmacy claims management, Medicare Part D services, benefit design consultation, preferred drug management programs, drug review and analysis, consulting services, data access, and reporting and information analysis. The Company's PBM services include owning and operating a network of mail and specialty pharmacies. In addition, the Company is a national provider of drug benefits to its customers under the federal government�� Medicare Part D program. The Company�� HCIT solutions include RxCLAIM, an on-line transaction processing system that provides instant adjudication of prescription drug claims, RxMAX, the Company�� rebate management system, RxTRACK, the Company�� data warehouse and analysis system, Zynchros, the Company�� suite of on-demand formulary management tools, the Company�� pharmacy management system! for retail, chain, institutional and mail-order pharmacies, as well as a number of other software products for customers in the pharmaceutical supply chain. The Company�� HCIT solutions are available on a license basis with on-going maintenance and support or on a transaction fee basis using an application service provider (ASP) model.

PBM Services

The Company�� informedRx offering is a suite of customizable PBM services that provide an alternative to traditional PBM offerings typically employed by health plans, government agencies and employers. The Company provides a range of pharmacy spend management solutions and information technology capabilities to managed care organizations, self-insured employer groups, unions, third party health care plan administrators, and state and federal government entities. Formulary Administration provides support for customers��existing formularies and preferred drug lists or collaborate to create models supported by formulary predictive modeling and impact analysis. Pharmacist, physician and member-focused intervention protocols provide controls to drive generics, preferred drug products and appropriate use. Formularies are administered based on specific plan designs, or by enabling customers with the tools to maintain their own custom formularies online.

The Company specializes in applying data-driven insights to help customers understand the medical risk drivers within their population and take a strategic approach to plan design. The Company provides benefit design configuration and support to customers, in accordance with mutually developed processes. Benefit designs can be modified online, in real time, by the Company or by the customer�� staff. Pharmacy Network Management provides a range of retail network options, including supporting existing networks or assisting customers in developing networks that meet specific geographic access requirements, desired price discounts, or other service requirements. A national! retail n! etwork, which consists of pharmacies in all 50 states and in Puerto Rico, Guam and the Virgin Islands, provides access to the Company�� customers.

Drug Utilization Review (DUR) is pre-dispensing DUR edit checks are performed on an online, real-time basis between mail and retail pharmacies to encourage appropriate drug utilization, enhance member outcomes, and reduce drug costs. All prescriptions are checked for member eligibility and plan design features and are then compared against previous histories of prescriptions filled by the same pharmacy, by other participating retail network pharmacies and by the mail service pharmacy. Clinical Services and Consulting provides consultative and technical expertise to augment, develop, deploy, and support any additional clinical programs. Reporting and Information Analysis Solutions provides two levels of reporting: a reporting package (which includes a menu of reports), and an online analytical decision support tool, RxTRACK. The Company offers mail and specialty services to its PBM members, as well as other members of its pharmacy network. suite of Web-based services that enables customers to interact with the claims processing system using a standardized protocol in a secure environment. A member Website, RxPORTAL, invites members to learn more about their prescription benefit programs, medication histories, drug information and related industry news. RxPROVIDER PORTAL is a Web-based interface that allows pharmacists and physicians to obtain information from RxCLAIM on a member's plan to assist in providing more cost effective prescription medications.

Healthcare IT

The Company's HCIT offerings deliver applications on a license, ASP, or fee-for-service basis to customers who administer and manage pharmacy benefits. HCIT products and services serve a diversified group of payor customers that include health plans, federal, state and provincial government programs, pharmacy benefit managers, workers' compensation programs! , and lon! g-term and/or chronic care facility operators. In addition, SXC's technology serves as the engine for the Company's service PBM solutions.

Technology Products and Services

RxCLAIM is an on-line transaction processing system designed to provide instant on-line adjudication of third-party prescription drug claims at the point of service, including claims management, as well as payment and billing support and real-time functionality for updating benefit, price, member, provider and drug details. RxCLAIM is designed to provide the Company�� customers control by facilitating the real-time processing of pharmacy claims and payments against eligibility, plan benefits, formularies, price, drug utilization review, prior authorization, and rebates in addition to many other features.

Other products

Integrail Pathfinder PRO is a software application that enables a array of users to understand the impact of healthcare resource allocation and medical decision-making through the incorporation of risk prediction and episode profiling technologies. The application offers users an intuitive system for integrating disparate data sources to pinpoint variations in resource utilization and care. IntegrailRx features the ability to measure and predict both pharmacy and total risk using pharmacy claims. RxBUILDER is a Web-based interface for formulary creation and maintenance utilizing a Medi-Span based product file. RxPORTAL allows customers to interact with the patient's formulary and drug history in a secure environment allowing patients and health plans to access industry tools and up to date information. RxAUTH is a prior authorization (PA) management solution, which offers automating the PA process from end-to-end. RxAUTH is also available in a Web-based application. RxMAX is a rebate management system that is designed to assist health plans in managing their relationships with pharmaceutical manufacturers through contract management, record keeping, calculating market share! , and cre! ating billing details and summaries. Zynchros provides a suite of on-demand formulary management tools to help payors effectively manage their formulary programs, and to maintain Medicare Part D compliance in their programs. Enhanced Coordination of Benefits integrates external data sources with unique algorithms and eligibility data to identify beneficiaries with other coverage. This enables accurate identification of third party liability in real-time prior to the claim being paid.

Medicare Part D

The Company has offered an array of services to the Medicare marketplace, all compliant with Centers for Medicare and Medicaid Services (CMS) regulations. As a full-service PBM and a National Prescription Drug Plan, the Company supports a variety of Medicare Part D Plan Sponsors. The Company provides prescription benefit management support for Medicare Advantage Prescription Drug plans (MAPDs) and prescription drug plans (PDPs), including implementation of specific Medicare Part D plan designs, creation and maintenance of Medicare Part D formularies (including CMS submission), CMS reporting requirements and consultative, proactive account management.

The Company competes with Express Scripts, Inc., CVS/Caremark Corporation and OptumRx.

Advisors' Opinion:

• [By Brian Pacampara]

  Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, health care IT services specialist Catamaran (NASDAQ: CTRX  ) has earned a coveted five-star ranking.

Top Supermarket Companies To Watch For 2014: Acceleron Pharma Inc (XLRN)

Acceleron Pharma Inc., incorporated on June 13, 2003, is a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of protein therapeutics for cancer and rare diseases. The Company�� research focuses on the biology of the Transforming Growth Factor-Beta (TGF-b) protein superfamily, a large and diverse group of molecules that are key regulators in the growth and repair of tissues throughout the human body. By coupling its discovery and development expertise, including its knowledge of the TGF-b superfamily, with its internal protein engineering and manufacturing capabilities, it has built a productive research and development platform that has generated clinical and preclinical protein therapeutic candidates with mechanisms of action.

The Company focuses on discovering and developing protein therapeutics that target a group of approximately 30 secreted proteins, or ligands, that are collectively referred to as the TGF-b superfamily. These ligands bind to subsets of 12 different receptors on the surface of cells, triggering intra-cellular changes in gene expression that guide cell growth and differentiation. The TGF-b superfamily ligands and their receptors represent an under-explored and diverse set of drug targets with the potential to yield therapeutics that modulate the growth and repair of diseased cells and tissues.

The Company has three internally discovered protein therapeutic candidates that are being studied in 12 ongoing Phase 2 clinical trials, focused on cancer and rare diseases. The Company�� two advanced protein therapeutic candidates, sotatercept and ACE-536, promote red blood cell production through a novel mechanism. Together with its collaboration partner, Celgene Corporation, the Company is developing sotatercept and ACE-536 to treat anemia and associated complications in patients with b-thalassemia and myelodysplastic syndromes (MDS). These red blood cell disorders are generally unresponsive to approved dru! gs. The Company�� third clinical stage protein therapeutic candidate, dalantercept, is designed to inhibit blood vessel formation through a mechanism that is distinct from, and potentially synergistic with, the dominant class of cancer drugs that inhibit blood vessel formation, the vascular endothelial growth factor (VEGF) pathway inhibitors. The Company is developing dalantercept primarily for use in combination with these products to produce better outcomes for cancer patients.

The Company and Celgene have conducted six human clinical trials with sotatercept in over 160 healthy volunteers and cancer patients. The Company has conducted one clinical trial with ACE-536 in healthy volunteers. In these studies, both sotatercept and ACE-536 caused a dose-dependent increase in the number of red blood cells. Based on these results, the Company and Celgene have initiated Phase II clinical trials with each of these protein therapeutic candidates in b-thalassemia and MDS. In the ongoing trial of sotatercept in patients with b-thalassemia, the Company has observed encouraging, dose-dependent increases in hemoglobin in a subset of patients at the two lowest dose levels.

Sotatercept is a soluble receptor fusion protein consisting of the extracellular domain of the activin receptor type IIA (ActRIIA) linked to the Fc domain of human IgG1. Sotatercept acts as a protein trap for TGF-b superfamily ligands that signal through the ActRIIA receptor. Sotatercept has increased red blood cells in multiple clinical trials. ACE-536 is a soluble receptor fusion protein consisting of a modified extracellular domain of the activin receptor type IIB (ActRIIB) linked to the Fc domain of human IgG1.

Advisors' Opinion:

• [By John Udovich]

  Yesterday, small cap biotech Acceleron Pharma Inc (NASDAQ: XLRN) rose 9.76%�plus shares are up 183.6% for retail investors since its September IPO, meaning its worth taking a closer look at the stock along with the performance of other biotech IPOs like BIND Therapeutics Inc (NASDAQ: BIND), Ophthotech Corp (NASDAQ: OPHT) and Foundation Medicine Inc (NASDAQ: FMI) which also debuted at the same time.

• [By Monica Gerson]

  Breaking news

  Acceleron Pharma (NASDAQ: XLRN) today announced that it has commenced an underwritten public offering of $100 million of its common stock. To read the full news, click here. XenoPort (NASDAQ: XNPT) announced today that it intends to offer and sell 10,000,000 shares of its common stock, subject to market and other conditions, in an underwritten public offering. To read the full news, click here. Affymetrix (NASDAQ: AFFX) today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its CytoScan庐 Dx Assay. To read the full news, click here. Verizon Communications (NYSE: VZ) and Intel (NASDAQ: INTC) today announced an agreement for Verizon to purchase from Intel the assets of Intel Media, a business division dedicated to the development of Cloud TV products and services. To read the full news, click here.

  Posted-In: Evercore Partners US Stock FuturesNews Eurozone Futures Global Pre-Market Outlook Markets